Defining Immunodeficiency in Heterotaxy Syndrome: Pilot Study Data

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Heterotaxy Syndrome
Trial Locations (1)

02115

Boston Children's Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Litron Laboratories

INDUSTRY

lead

Boston Children's Hospital

OTHER

NCT01929967 - Defining Immunodeficiency in Heterotaxy Syndrome: Pilot Study Data | Biotech Hunter | Biotech Hunter